Discordance Between Patient Self-report and Clinician Record of Adverse Drug Reactions to Drug-Resistant Tuberculosis Treatment in Johannesburg, 2015 – 2018
- DR-TB is a threat to global tuberculosis prevention, control and treatment programs.
- Treatment is complicated by adverse drug reactions (ADRs) to second-line TB drugs.
- An adverse event is any undesirable experience associated with the use of a medical product in a patient.
- There is a lack of data on the discordance between patient self-report and clinician records of ADRs during DR-TB treatment, which may impact treatment outcomes such as adherence or retention in care.